India & Neighboring Countries POC Molecular Diagnostics Market Outlook 2026

Point of Care (PoC) molecular diagnostic solutions offers improved standard of care by combination of rapid diagnostic techniques and treatment decisions upon the very first visit by the patient. PoC molecular diagnostic products include kits & assays, analyzers, and software & services which are extensively used for various applications including respiratory diseases, infectious diseases, hematology, and various others. The India and neighboring countries PoC molecular diagnostics market is estimated to grow with a CAGR of 16.34% during the forecast period, i.e., 2021-2026. Factors such as the growing concern for the prevalence of infectious diseases, as well as for the increasing focus of the government of the nations in these countries to develop their healthcare infrastructure are anticipated to drive the market growth. Further, the increasing healthcare expenditure from these countries is also anticipated to drive the market growth. The market in these countries is also anticipated to grow on account of the growing population and the increasing burden of infectious diseases on these countries. The India and neighboring countries PoC molecular diagnostics market is further anticipated to reach around USD 6400 Million by the end of 2026 from a revenue of close to USD 1700 Million in the year 2019.

The market is segmented into various segments, which include segmentation by end user, product type, technology type, application and by country. Based on technology type, the market is segmented into PCR, DNA microarray, isothermal amplification, genetic sequencing, hybridization, and others, out of which, the PCR segment in the clinics end user segment is anticipated to hold the largest market share and generate a revenue of about USD 580 Million by the end of 2021.

On the basis of country, the market is segmented into India, Bangladesh, Pakistan, Sri-Lanka, Nepal, and Maldives, out of which, the market in India is anticipated to hold the largest market share throughout the forecast period. Further, the market in the country is projected to gain a revenue of around USD 5300 Million by the end of 2026, owing to the growing economy and the increasing health expenditure by the government of the nation. The market in the country is further anticipated to grow with the highest CAGR of 17% approximately during the forecast period.

Some of the key players in the India and neighboring countries PoC molecular diagnostics market that are included in our report are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Molbio Diagnostics Pvt. Ltd., bioMerieux SA, Becton, Dickinson and Company, QuantMDx Group Limited, Beckman Coulter, Inc., Abbott, MedGenome, Chembio Diagnostics, Inc., Sysmex Europe GmbH, Cepheid, and others.